Clinical Trials Directory

Trials / Completed

CompletedNCT00000347

Risperidone for Treatment of Cocaine Dependence in Outpatients - 12

Risperidone for Treatment of Cocaine Dependence in Outpatients

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate pharmacological efficacy and clinical safety of risperidone in the treatment of cocaine and amphetamine dependence.

Conditions

Interventions

TypeNameDescription
DRUGRisperidone

Timeline

Start date
1997-07-01
Primary completion
1998-08-01
Completion
1998-09-01
First posted
1999-09-21
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000347. Inclusion in this directory is not an endorsement.